Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study.
Xiang Q, Wang Z, Mu G, Xie Q, Liu Z, Zhou S, Zhang H, Wang Z, Jiang J, Hu K, Zhang Y, Zhao Z, Yuan D, Guo L, Wu T, Zhang J, Wang N, Xiang J, Gu Z, Sun J, Cui Y.
Xiang Q, et al. Among authors: hu k.
Clin Transl Med. 2023 May;13(5):e1263. doi: 10.1002/ctm2.1263.
Clin Transl Med. 2023.
PMID: 37203300
Free PMC article.